GW26-e1798 Successful Treatment of a LQT8 Case with Mexiletine: 4 years of experience

Results During the first two years of treatment of mexiletine at a maintenance dose of 150 to 200 mg daily, her ECGs and the Holter monitoring revealed no 2:1 AVB and TWA, blunted QT/RR relationship and QTc in a range from 500 to 560 ms. During this period, the patient successfully underwent two syn...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 66; no. 16; pp. C176 - C177
Main Authors Li, Guoliang, Xue, Xiaolin, Han, Wenqi, Sun, Chaofeng, Yan, Ganxin
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 20.10.2015
Elsevier Limited
Subjects
Cardiac arrhythmia
Cardiology
Cardiovascular
Electrocardiography
Internal Medicine
Online AccessGet full text

Cover

More Information
Summary:Results During the first two years of treatment of mexiletine at a maintenance dose of 150 to 200 mg daily, her ECGs and the Holter monitoring revealed no 2:1 AVB and TWA, blunted QT/RR relationship and QTc in a range from 500 to 560 ms. During this period, the patient successfully underwent two syndactyly repair surgeries although the anesthesiologist reported occurrence of one episode of non-sustained polymorphic ventricular tachycardia during her second operation.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.06.675